NLRP3 and metabolic dysfunction-associated steatotic liver disease: Although there are relatively few reports about candidalysin in MASLD, existing studies have shown that candidalysin may activate the NLRP3 inflammasome, which plays a significant role in the development of liver inflammation and fibrosis in MASH [177, 178].